Vincent Bours
- Cancer Research top 0.1%
- NF-κB Signaling Pathways 59
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 11
- Immunology top 0.5%
- Immune Response and Inflammation 21
- Molecular Biology top 1%
- Natural product bioactivities and synthesis 11
- Genetics top 1%
- Hemoglobinopathies and Related Disorders 16
- Oncology top 1%
- Cytokine Signaling Pathways and Interactions 14
-
- Pituitary Gland Disorders and Treatments 11
- Co-authors
- Marie‐Paule MervilleAlain ChariotPatrick ViatourUlrich SiebenlistGiuseppina BonizziMohamed Bentires‐AljPierre A. RobeJacques Gielen
- Journals
- Biochemical Pharmacology (12 papers)Oncogene (11 papers)Molecular and Cellular Biology (9 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Vincent Bours
250 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 4.4k
- Immunology 3.5k
- Molecular Biology 5.7k
- Genetics 841
- Oncology 2.1k
Countries citing papers authored by Vincent Bours
This map shows the geographic impact of Vincent Bours's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Bours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Bours more than expected).
Fields of papers citing papers by Vincent Bours
This network shows the impact of papers produced by Vincent Bours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Bours. The network helps show where Vincent Bours may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vincent Bours, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 16 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 7 | |
| 8 | 2020 | 51 | |
| 9 | 2019 | 14 | |
| 10 | 2017 | 6 | |
| 11 | Epidemiological data on sickle cell disease in Belgium | 2015 | 2 |
| 12 | 2014 | 44 | |
| 13 | 2010 | 44 | |
| 14 | High Incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas | 2009 | 5 |
| 15 | Aryl Hydrocarbon Receptor interacting Protein Gene Mutations in Bulgarian FIPA and Young Sporadic Pituitary Adenoma Patients | 2008 | 7 |
| 16 | Germline AIP, MEN1, PRKAR1A, CDKN1B (p27Kip1) and CDKN2C (p18INK4c) gene mutations in a large cohort of pediatric patients with pituitary adenomas occurring in isolation or with associated syndromic features | 2008 | 10 |
| 17 | Overexpression of airway CD39 in transgenic mice enhances lipopolysaccharide-induced inflammation. | 2008 | 1 |
| 18 | Identification of the signalling pathways required for interleukin-1 beta stimulation of osteoprotegerin synthesis in osteoblastic cells | 2003 | 1 |
| 19 | 2000 | 102 | |
| 20 | 2000 | 108 |
About Vincent Bours
Vincent Bours is a scholar working on Cancer Research, Genetics, Immunology, Genetics and Hematology, having authored 252 papers that have together received 11.9k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (59 papers), Immune Response and Inflammation (21 papers), Hemoglobinopathies and Related Disorders (16 papers), Cytokine Signaling Pathways and Interactions (14 papers), MicroRNA in disease regulation (12 papers), Pituitary Gland Disorders and Treatments (11 papers), Natural product bioactivities and synthesis (11 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Cancer Research (4.4k citations), Immunology (3.5k citations), Molecular Biology (5.7k citations), Genetics (841 citations) and Oncology (2.1k citations). Vincent Bours has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Marie‐Paule Merville, Alain Chariot, Patrick Viatour, Ulrich Siebenlist, Giuseppina Bonizzi, Mohamed Bentires‐Alj, Pierre A. Robe, Jacques Gielen, Kathleen Kelly and Marie-Paule Merville. Their work appears in journals such as Biochemical Pharmacology, Oncogene, Molecular and Cellular Biology, Journal of Biological Chemistry and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.